Legend Biotech (LEGN) Debt Ratio (2021 - 2025)
Legend Biotech filings provide 5 years of Debt Ratio readings, the most recent being 0.18 for Q4 2025.
- On a quarterly basis, Debt Ratio rose 2.06% to 0.18 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.18, a 2.06% increase, with the full-year FY2025 number at 0.18, up 2.06% from a year prior.
- Debt Ratio hit 0.18 in Q4 2025 for Legend Biotech, up from 0.08 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.22 in Q1 2023 to a low of 0.0 in Q2 2021.
- Median Debt Ratio over the past 5 years was 0.16 (2024), compared with a mean of 0.15.
- Biggest five-year swings in Debt Ratio: surged 82.19% in 2022 and later crashed 51.19% in 2025.
- Legend Biotech's Debt Ratio stood at 0.11 in 2021, then skyrocketed by 82.19% to 0.2 in 2022, then decreased by 22.37% to 0.15 in 2023, then rose by 18.5% to 0.18 in 2024, then grew by 2.06% to 0.18 in 2025.
- The last three reported values for Debt Ratio were 0.18 (Q4 2025), 0.08 (Q3 2025), and 0.18 (Q2 2025) per Business Quant data.